| Cannabidiol–drug interaction in cancer patients: A retrospective study in a real‐life setting M Guedon, A Le Bozec, M Brugel, J Clarenne, C Carlier, M Perrier, ... British Journal of Clinical Pharmacology 89 (7), 2322-2328, 2023 | 10 | 2023 |
| Using national data to describe characteristics and determine acceptance factors of pharmacists’ interventions: a six-year longitudinal study M Bouzeid, J Clarenne, C Mongaret, H Pluchart, S Chanoine, C Vermorel, ... International Journal of Clinical Pharmacy 45 (2), 430-441, 2023 | 10 | 2023 |
| Nightmares and hallucinations with aprepitant and opium powder: a suspected drug–drug interaction G Narjoux, J Clarenne, B Azzouz, PS Zeller, F Slimano, O Bouché British Journal of Clinical Pharmacology 85 (2), 454-456, 2019 | 4 | 2019 |
| Clinical relevance of pharmacist Intervention: Development of a named entity recognition model on Unstructured comments J Clarenne, S Priou, A Alixe, O Martin, C Mongaret, P Bedouch Public Health and Informatics, 492-493, 2021 | 3 | 2021 |
| Economical simulations for the optimal use of anti-programmed cell death-1 in advanced melanoma patients: Report of a budget impact analysis J Clarenne, C Boulanger, A Maréchal, L Visseaux, F Slimano Journal of Oncology Pharmacy Practice 26 (5), 1216-1219, 2020 | 3 | 2020 |
| Clinical and Organizational Impacts of Medical Ordering Settings on Patient Pathway and Community Pharmacy Dispensing Process: The Prospective ORDHOSPIVILLE Study J Clarenne, J Gravoulet, V Chopard, J Rouge, A Lestrille, F Dupuis, ... Pharmacy 10 (1), 2, 2021 | 2 | 2021 |
| Contribution des pharmaciens d’officine au traitement des cystites simples (chez la femme): une étude de la portée I Badran, J Clarenne, F Reffuveille, A Lestrille, L Aubert, J Gravoulet, ... Le Pharmacien Clinicien 59 (1), 33-45, 2024 | 1 | 2024 |
| Perception, assessment and expectation by general practitioners of a medication review information support provided from one oncology day-hospital K Smati, F SLIMANO, G OUDOT, C CARLIER, J CLARENNE, L AUBERT, ... Support Care Cancer 32, 434, 2024 | 1 | 2024 |
| Prix de l’ordre des pharmaciens 2022: projet PARTAGE GHT 49 L Spiesser-Robelet, E Matusik, S Belhadj, J Clarenne, ... Le Pharmacien Clinicien 58 (2), 101-103, 2023 | 1 | 2023 |
| Impact des interventions pharmaceutiques selon l’échelle multidimensionnelle CLEO (CLinical, Economic and Organizational): analyse descriptive sur 40 mois J Clarenne, C Mongaret, C Vermorel, JL Bosson, M Bourdelin, B Charpiat, ... Le Pharmacien Clinicien 57 (4), e32, 2022 | 1 | 2022 |
| Training pharmacy students to conduct targeted interviews on oral anticoagulants: Development and evaluation of training using healthcare simulation L Jamart, J Clarenne, F Slimano, D Hettler, P Quillet Annales pharmaceutiques francaises 83 (1), 100-111, 2025 | | 2025 |
| Formation des étudiants en pharmacie conduisant des entretiens ciblés sur les anticoagulants oraux: élaboration et évaluation d’une formation par la simulation en santé L Jamart, J Clarenne, F Slimano, D Hettler, P Quillet Annales Pharmaceutiques Françaises 83 (1), 100-111, 2025 | | 2025 |
| A machine learning-based clinical predictive tool to identify patients at high risk of medication errors A Abdo, L Gallay, T Vallecillo, J Clarenne, P Quillet, V Vuiblet, R Merieux Scientific Reports 14 (1), 32022, 2024 | | 2024 |
| Characteristics of hospital pharmacist interventions and their clinical, economic and organizational impacts: a five-year observational study on the French National Observatory J Clarenne, C Mongaret, C Vermorel, JL Bosson, SC Gangloff, ... International Journal of Clinical Pharmacy, 1-9, 2024 | | 2024 |
| Preliminary guidelines for the detection and management of drug-related problems in cancer patients with type 2 diabetes mellitus: a practical resource for oncology pharmacists C Gossery, J Clarenne, S Barraud, M Brugel, M Boulin, C Carlier, ... Supportive Care in Cancer 32 (12), 791, 2024 | | 2024 |
| Article 51 et pharmacie clinique: focus sur le projet IATROPREV B Décaudin, A Lenglet, E Jouhanneau, E Matusik, S Belhadj, J Clarenne Le Pharmacien Clinicien 59 (4), 403-406, 2024 | | 2024 |
| Article 51 et pharmacie clinique: focus sur le projet OCTAVE A Carde, E Jouhanneau, E Matusik, S Belhadj, J Clarenne Le Pharmacien Clinicien 59 (4), 398-402, 2024 | | 2024 |
| Article 51 et pharmacie clinique: focus sur le projet MEDISIS E Dufay, A Frapsauce, C Antoine, MCM Carvalho, E Hamilius, ... Le Pharmacien Clinicien 59 (4), 407-411, 2024 | | 2024 |
| Traitement de la cystite simple en pharmacie d’officine: regards croisés de pharmaciens d’officine et d’étudiants en 6e année de pharmacie dans le contexte de la dispensation … C Thurot, J Clarenne, F Dupuis, I Badran, A Lestrille, C Mongaret, ... Le Pharmacien Clinicien, 2024 | | 2024 |
| A 14-year retrospective of HER2+ metastatic breast cancer treatment at one comprehensive cancer center: Impact of the trastuzumab/pertuzumab and trastuzumab-emtansine sequence … V Lepage, J Clarenne, B Fulbert, F Slimano, C Jouannaud, D Parent Journal of Oncology Pharmacy Practice, 10781552241289923, 2024 | | 2024 |
